Aptevo Therapeutics Inc. files S-1 registration statement to raise capital through a public offering, signaling growth plans in the pharmaceutical sector.
| Name | Aptevo Therapeutics Inc. |
|---|---|
| CIK | 0001671584 |
| Tickers | APVO |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 811567056 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 206-838-0500 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Aptevo Therapeutics Inc. files S-1 registration statement to raise capital through a public offering, signaling growth plans in the pharmaceutical sector.
Aptevo Therapeutics Inc. shares its Q3 financial results, focusing on advancements in pharmaceutical preparations and ongoing projects.
Aptevo Therapeutics Inc. reports its Q3 2026 financial results, shedding light on its operational performance and industry trends.
Aptevo Therapeutics Inc. announces a special stockholder meeting on December 14, 2026, to discuss key proposals including a reverse stock split.
Aptevo Therapeutics has entered into agreements to induce warrant exercises, aiming to raise approximately $18 million for operational support.
Aptevo Therapeutics Inc. shares new preclinical data from its multispecific platform at the SITC 2026 Annual Meeting, signaling advancements in cancer treatment.
Aptevo Therapeutics announces a significant reduction in infusion-related reactions for mipletamig, marking a key milestone in its clinical development.
Aptevo Therapeutics has filed a prospectus supplement to raise up to $2.3 million, reflecting its ongoing capital enhancement efforts in the pharmaceutical sector.
Aptevo Therapeutics announces that ten AML patients advanced to stem cell transplant after treatment with mipletamig, highlighting progress in cancer therapies.
Aptevo Therapeutics Inc. will showcase its multispecific platform at the SITC Annual Meeting from November 4-8, 2026, in Phoenix, Arizona.
748 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | S-1 | S-1 | 0001193125-26-470268 | 333-300184 | 261579389 | 33 | 1861633 | 1 | 1 | |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001649553-26-000140 | 005-89584 | 261558808 | 34 | 11586 | |||
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-462265 | 001-37746 | 261555772 | 34 | 8314040 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-462254 | 001-37746 | 261555725 | 34 | 204281 | 1 | 1 |
| 2026-11-12 | PRE 14A | PRE 14A | 0001193125-26-458711 | 001-37746 | 261549585 | 34 | 2826579 | |||
| 2026-11-12 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-26-458751 | 001-37746 | 261548203 | 34 | 642323 | 1 | 1 |
| 2026-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-051277 | 005-89584 | 261544687 | 34 | 11833 | |||
| 2026-11-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-452737 | 001-37746 | 261534006 | 34 | 194371 | 1 | 1 |
| 2026-11-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-448714 | 001-37746 | 261525019 | 34 | 199325 | 1 | 1 |
| 2026-11-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-442031 | 001-37746 | 261509386 | 34 | 215035 | 1 | 1 |
| 2026-10-30 | 424B5 | 424B5 | 0001193125-26-441770 | 333-284969 | 261508544 | 33 | 28756 | |||
| 2026-10-26 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-431079 | 001-37746 | 261483594 | 34 | 186443 | 1 | 1 |
| 2026-10-23 | 8-K | 8-K | 1.01,3.03,9.01 | 0001193125-26-430419 | 001-37746 | 261482202 | 34 | 202149 | 1 | 1 |
| 2026-10-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-421076 | 001-37746 | 261458391 | 34 | 174144 | 1 | 1 |
| 2026-09-25 | S-8 | S-8 | 0001193125-26-402813 | 333-299137 | 261410381 | 33 | 416168 | 1 | 1 | |
| 2026-09-24 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-400213 | 001-37746 | 261402196 | 34 | 172037 | 1 | 1 |
| 2026-09-23 | 8-K | 8-K | 5.07 | 0001193125-26-399545 | 001-37746 | 261401432 | 34 | 181403 | 1 | 1 |
| 2026-09-03 | 424B4 | 424B4 | 0001193125-26-381149 | 333-298483 | 261356821 | 33 | 802525 | |||
| 2026-09-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-381098 | 001-37746 | 261356761 | 34 | 185863 | 1 | 1 |
| 2026-09-02 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002871 | 333-298483 | 261356570 | 33 | 1744 | ||
| 2026-08-31 | DEF 14A | DEF 14A | 0001193125-26-376763 | 001-37746 | 261347785 | 34 | 11964058 | 1 | 1 | |
| 2026-08-31 | CORRESP | filename1.htm | 0001193125-26-377083 | 11153 | ||||||
| 2026-08-27 | UPLOAD | filename1.pdf | 0000000000-26-008467 | 333-298483 | 148242 | |||||
| 2026-08-26 | D | xslFormDX01/primary_doc.xml | 06c | 0001193125-26-368286 | 021-595477 | 261322667 | 33 | 12005 | ||
| 2026-08-21 | PRE 14A | PRE 14A | 0001193125-26-361119 | 001-37746 | 261304895 | 34 | 12710567 | 1 | 1 | |
| 2026-08-21 | S-1 | S-1 | 0001193125-26-361103 | 333-298483 | 261304800 | 33 | 1809660 | 1 | 1 | |
| 2026-08-21 | 8-K | 8-K | 5.07 | 0001193125-26-361079 | 001-37746 | 261304683 | 34 | 178947 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001649553-26-000098 | 005-89584 | 261280077 | 34 | 11862 | |||
| 2026-08-14 | 10-Q | 10-Q | 0001193125-26-350559 | 001-37746 | 261276314 | 34 | 10853064 | 1 | 1 | |
| 2026-08-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-350537 | 001-37746 | 261276296 | 34 | 210209 | 1 | 1 |
| 2026-08-13 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-26-349380 | 001-37746 | 261274219 | 34 | 1889269 | 1 | 1 |
| 2026-08-10 | 4 | 4 | 0001193125-26-343080 | 6821 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343079 | 6895 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343077 | 6951 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343076 | 6923 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343073 | 8413 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343072 | 6831 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343070 | 11976 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343069 | 6834 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343067 | 6836 | ||||||
| 2026-08-10 | 4 | 4 | 0001193125-26-343065 | 6832 | ||||||
| 2026-07-31 | DEF 14A | DEF 14A | 0001193125-26-328604 | 001-37746 | 261228701 | 34 | 14102510 | 1 | 1 | |
| 2026-07-31 | ARS | ARS | 0001193125-26-328465 | 001-37746 | 261228411 | 34 | 1868555 | |||
| 2026-07-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-318056 | 001-37746 | 261205754 | 34 | 184098 | 1 | 1 |
| 2026-07-24 | S-8 | S-8 | 0001193125-26-316068 | 333-297675 | 261201524 | 33 | 433097 | 1 | 1 | |
| 2026-06-30 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-26-290473 | 001-37746 | 261140484 | 34 | 188260 | 1 | 1 |
| 2026-06-22 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001666270-26-000004 | 005-89584 | 261105753 | 34 | 7064 | |||
| 2026-06-22 | 3 | PRIMARY DOCUMENT | 0001666270-26-000003 | 4744 | ||||||
| 2026-05-28 | 3 | 3 | 0001193125-26-245818 | 11415 | ||||||
| 2026-05-27 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-26-241867 | 001-37746 | 261026101 | 34 | 222347 | 1 | 1 |
| 2026-05-13 | 10-Q | 10-Q | 0001193125-26-221661 | 001-37746 | 26973486 | 34 | 5964636 | 1 | 1 | |
| 2026-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-221593 | 001-37746 | 26973192 | 34 | 206528 | 1 | 1 |
| 2026-05-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-208958 | 001-37746 | 26948385 | 34 | 196770 | 1 | 1 |
| 2026-03-26 | 10-K | 10-K | 0001193125-26-126278 | 001-37746 | 26798463 | 34 | 13008300 | 1 | 1 | |
| 2026-03-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-126190 | 001-37746 | 26798052 | 34 | 356385 | 1 | 1 |
| 2026-03-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-100539 | 001-37746 | 26740804 | 34 | 188979 | 1 | 1 |
| 2026-02-19 | 8-K | 8-K | 5.07 | 0001193125-26-057707 | 001-37746 | 26650961 | 34 | 171617 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001127 | 005-89584 | 26641980 | 34 | 11067 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-26-000020 | 005-89584 | 26639885 | 34 | 11809 | |||
| 2026-02-03 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-034473 | 001-37746 | 26590216 | 34 | 217549 | 1 | 1 |
| 2026-01-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000430 | 333-293010 | 26585539 | 33 | 1743 | ||
| 2026-01-30 | 424B4 | 424B4 | 0001193125-26-032011 | 333-293010 | 26584305 | 33 | 399685 | |||
| 2026-01-29 | CORRESP | filename1.htm | 0001193125-26-029443 | 9920 | ||||||
| 2026-01-29 | UPLOAD | filename1.pdf | 0000000000-26-001091 | 333-293010 | 40059 | |||||
| 2026-01-28 | S-1 | S-1 | 0001193125-26-027200 | 333-293010 | 26572495 | 33 | 1387182 | 1 | 1 | |
| 2026-01-26 | DEF 14A | DEF 14A | 0001193125-26-022560 | 001-37746 | 26560528 | 34 | 1070934 | 1 | 1 | |
| 2026-01-16 | PRE 14A | PRE 14A | 0001193125-26-015339 | 001-37746 | 26539468 | 34 | 1715377 | 1 | 1 | |
| 2026-01-09 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-26-008318 | 001-37746 | 26521392 | 34 | 700700 | 1 | 1 |
| 2025-12-29 | 8-K | 8-K | 5.03,9.01 | 0001193125-25-335497 | 001-37746 | 251609992 | 34 | 186818 | 1 | 1 |
| 2025-12-09 | 8-K | 8-K | 9.01 | 0001193125-25-312972 | 001-37746 | 251560036 | 34 | 214573 | 1 | 1 |
| 2025-11-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003381 | 333-290663 | 251523696 | 33 | 1744 | ||
| 2025-11-25 | 424B4 | 424B4 | 0001193125-25-297513 | 333-290663 | 251522179 | 33 | 404144 | |||
| 2025-11-24 | CORRESP | filename1.htm | 0001193125-25-293460 | 10129 | ||||||
| 2025-11-12 | 4 | 4 | 0001193125-25-277771 | 4274 | ||||||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000070858-25-000408 | 005-89584 | 251461802 | 34 | 110663 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-269598 | 001-37746 | 251458561 | 34 | 7479379 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-269470 | 001-37746 | 251458207 | 34 | 406187 | 1 | 1 |
| 2025-10-30 | 8-K | 8-K | 1.01,3.03,9.01 | 0001193125-25-258665 | 001-37746 | 251436161 | 34 | 195262 | 1 | 1 |
| 2025-10-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000070858-25-000377 | 005-89584 | 251377133 | 34 | 110614 | |||
| 2025-10-03 | 4 | PRIMARY DOCUMENT | 0000070858-25-000374 | 10204 | ||||||
| 2025-10-03 | 3 | PRIMARY DOCUMENT | 0000070858-25-000373 | 12315 | ||||||
| 2025-10-01 | S-1 | S-1 | 0001193125-25-226825 | 333-290663 | 251365035 | 33 | 1386359 | 1 | 1 | |
| 2025-09-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004113 | 005-89584 | 251321084 | 34 | 17100 | |||
| 2025-09-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-205107 | 001-37746 | 251318051 | 34 | 209961 | 1 | 1 |
| 2025-09-04 | 8-K | 8-K | 8.01,9.01 | 0001671584-25-000005 | 001-37746 | 251293652 | 34 | 203010 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001079973-25-001313 | 005-89584 | 251221755 | 34 | 8102 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000151 | 005-89584 | 251217282 | 34 | 11694 | |||
| 2025-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001641172-25-023309 | 005-89584 | 251208877 | 34 | 11693 | |||
| 2025-08-11 | 10-Q | 10-Q | 0000950170-25-106247 | 001-37746 | 251200287 | 34 | 7059840 | 1 | 1 | |
| 2025-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-106246 | 001-37746 | 251200283 | 34 | 393306 | 1 | 1 |
| 2025-08-08 | 4 | 4 | 0000950170-25-105942 | 5218 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105938 | 5337 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105936 | 5214 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105935 | 5261 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105933 | 5216 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105930 | 5273 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105922 | 5264 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105919 | 5220 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105894 | 5291 | ||||||
| 2025-08-08 | 4 | 4 | 0000950170-25-105887 | 5205 | ||||||
| 2025-08-08 | 424B4 | 424B4 | 0000950170-25-105823 | 333-288959 | 251198362 | 33 | 401605 | |||
| 2025-08-01 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002457 | 333-288959 | 251177853 | 33 | 1744 | ||
| 2025-07-31 | CORRESP | filename1.htm | 0000950170-25-100776 | 11467 | ||||||
| 2025-07-30 | UPLOAD | filename1.pdf | 0000000000-25-008051 | 333-288959 | 40082 | |||||
| 2025-07-25 | S-1 | S-1 | 0000950170-25-098788 | 333-288959 | 251151868 | 33 | 1232240 | |||
| 2025-07-24 | 8-K | 8-K | 5.07 | 0000950170-25-098429 | 001-37746 | 251147982 | 34 | 210992 | 1 | 1 |
| 2025-07-21 | 4 | 4 | 0000950170-25-097283 | 6666 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097280 | 6681 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097279 | 6679 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097278 | 6675 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097274 | 6677 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097272 | 6835 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097271 | 6807 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097269 | 6767 | ||||||
| 2025-07-21 | 4 | 4 | 0000950170-25-097267 | 6805 | ||||||
| 2025-07-09 | 3 | 3 | 0000950170-25-094856 | 18496 | ||||||
| 2025-07-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-066378 | 005-89584 | 251110596 | 34 | 20646 | |||
| 2025-07-03 | DEF 14A | DEF 14A | 0000950170-25-093924 | 001-37746 | 251107670 | 34 | 4475355 | 1 | 1 | |
| 2025-07-03 | ARS | ARS | 0000950170-25-093869 | 001-37746 | 251105721 | 34 | 4850905 | |||
| 2025-07-01 | 8-K | 8-K | 8.01 | 0000950170-25-092318 | 001-37746 | 251097329 | 34 | 145180 | 1 | 1 |
| 2025-06-30 | 8-K | 8-K | 8.01 | 0000950170-25-091581 | 001-37746 | 251092218 | 34 | 148004 | 1 | 1 |
| 2025-06-25 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-057838 | 005-89584 | 251074105 | 34 | 21738 | |||
| 2025-06-25 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-001833 | 005-89584 | 251073995 | 34 | 18142 | |||
| 2025-06-23 | PRE 14A | PRE 14A | 0000950170-25-089090 | 001-37746 | 251066029 | 34 | 4420674 | 1 | 1 | |
| 2025-06-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001079973-25-001053 | 005-89584 | 251065024 | 34 | 7831 | |||
| 2025-06-23 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001079973-25-001052 | 005-89584 | 251065015 | 34 | 7987 | |||
| 2025-06-23 | 8-K | 8-K | 4.01,9.01 | 0000950170-25-088970 | 001-37746 | 251064974 | 34 | 163158 | 1 | 1 |
| 2025-06-20 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-088592 | 001-37746 | 251062376 | 34 | 289858 | 1 | 1 |
| 2025-06-20 | 424B5 | 424B5 | 0000950170-25-088588 | 333-284969 | 251062298 | 33 | 26240 | |||
| 2025-06-20 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-25-088494 | 001-37746 | 251061322 | 34 | 1455078 | 1 | 1 |
| 2025-06-20 | 424B4 | 424B4 | 0000950170-25-088195 | 333-288061 | 251059258 | 33 | 983701 | |||
| 2025-06-18 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001965 | 333-288061 | 251058906 | 33 | 1744 | ||
| 2025-06-18 | S-1MEF | S-1MEF | 0000950170-25-087813 | 333-288134 | 251056346 | 33 | 264143 | |||
| 2025-06-17 | 8-K | 8-K | 1.01,3.02,9.01 | 0000950170-25-087368 | 001-37746 | 251053479 | 34 | 671982 | 1 | 1 |
| 2025-06-16 | CORRESP | filename1.htm | 0000950170-25-086571 | 11746 | ||||||
| 2025-06-16 | S-1 | S-1 | 0000950170-25-086548 | 333-288061 | 251048578 | 33 | 2765429 | |||
| 2025-06-04 | UPLOAD | filename1.pdf | 0000000000-25-005902 | 377-08065 | 40286 | |||||
| 2025-05-30 | DRS | filename1.htm | 0000950123-25-005937 | 377-08065 | 251012264 | 33 | 2536250 | |||
| 2025-05-28 | 424B3 | 424B3 | 0000950170-25-078328 | 333-287244 | 25995412 | 33 | 989081 | |||
| 2025-05-23 | 8-K | 8-K | 5.03,9.01 | 0000950170-25-077089 | 001-37746 | 25983338 | 34 | 192389 | 1 | 1 |
| 2025-05-22 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001715 | 333-287244 | 25979104 | 33 | 1743 | ||
| 2025-05-22 | 8-K | 8-K | 3.01,8.01,9.01 | 0000950170-25-076482 | 001-37746 | 25978368 | 34 | 315347 | 1 | 1 |
| 2025-05-22 | 424B5 | 424B5 | 0000950170-25-076336 | 333-284969 | 25977306 | 33 | 25704 | |||
| 2025-05-21 | CORRESP | filename1.htm | 0000950170-25-075622 | 11343 | ||||||
| 2025-05-20 | UPLOAD | filename1.pdf | 0000000000-25-005388 | 333-287244 | 40094 | |||||
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-072622 | 001-37746 | 25953041 | 34 | 6422511 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-072594 | 001-37746 | 25952728 | 34 | 369431 | 1 | 1 |
| 2025-05-13 | S-1 | S-1 | 0000950170-25-070551 | 333-287244 | 25941678 | 33 | 1755521 | |||
| 2025-05-13 | RW | RW | 0000950170-25-069821 | 333-286952 | 25937258 | NE | 12935 | |||
| 2025-05-13 | RW | RW | 0000950170-25-069820 | 333-285476 | 25937256 | NE | 12992 | |||
| 2025-05-02 | S-3 | S-3 | 0000950170-25-062910 | 333-286952 | 25909710 | 33 | 1356705 | |||
| 2025-04-29 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-060317 | 001-37746 | 25889093 | 34 | 257258 | 1 | 1 |
| 2025-04-29 | 424B5 | 424B5 | 0000950170-25-060303 | 333-284969 | 25888956 | 33 | 25473 | |||
| 2025-04-28 | 424B4 | 424B4 | 0000950170-25-058974 | 333-284969 | 25876031 | 33 | 1318953 | |||
| 2025-04-28 | 8-K | 8-K | 1.01,2.02,8.01,9.01 | 0000950170-25-058966 | 001-37746 | 25875997 | 34 | 687801 | 1 | 1 |
| 2025-04-25 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-035548 | 005-89584 | 25873977 | 34 | 16356 | |||
| 2025-04-25 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001553350-25-000023 | 005-89584 | 25873786 | 34 | 7669 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0000950170-25-058694 | 001-37746 | 25873774 | 34 | 1614034 | |||
| 2025-04-25 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001553350-25-000022 | 005-89584 | 25873633 | 34 | 8085 | |||
| 2025-04-22 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-25-056736 | 001-37746 | 25857892 | 34 | 831933 | 1 | 1 |
| 2025-04-22 | 424B4 | 424B4 | 0000950170-25-056475 | 333-284969 | 25855024 | 33 | 1977528 | |||
| 2025-04-18 | D | xslFormDX01/primary_doc.xml | 06c | 0001671584-25-000001 | 021-544060 | 25849666 | 33 | 6040 | ||
| 2025-04-10 | PRE 14A | PRE 14A | 0000950170-25-052922 | 001-37746 | 25829150 | 34 | 882752 | |||
| 2025-04-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000060 | 005-89584 | 25826860 | 34 | 15118 | |||
| 2025-04-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-030378 | 005-89584 | 25826029 | 34 | 16911 | |||
| 2025-04-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-001026 | 005-89584 | 25823312 | 34 | 17420 | |||
| 2025-04-07 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001079973-25-000599 | 005-89584 | 25818787 | 34 | 7711 | |||
| 2025-04-04 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-25-051143 | 001-37746 | 25814953 | 34 | 1371167 | 1 | 1 |
| 2025-04-04 | 424B4 | 424B4 | 0000950170-25-050924 | 333-284969 | 25812329 | 33 | 2000025 | |||
| 2025-04-01 | S-1/A | S-1/A | 0000950170-25-048016 | 333-285476 | 25796523 | 33 | 1817057 | |||
| 2025-03-27 | S-1/A | S-1/A | 0000950170-25-046199 | 333-285476 | 25780509 | 33 | 2040189 | |||
| 2025-03-27 | S-1/A | S-1/A | 0000950170-25-045728 | 333-285476 | 25775278 | 33 | 2020485 | |||
| 2025-03-25 | S-1/A | S-1/A | 0000950170-25-044078 | 333-285476 | 25765733 | 33 | 2872092 | |||
| 2025-03-20 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-25-042340 | 001-37746 | 25754618 | 34 | 19772288 | 1 | 1 |
| 2025-03-04 | 4 | 4 | 0000950170-25-032201 | 10350 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032197 | 10333 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032187 | 10332 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032183 | 10395 | ||||||
| 2025-03-03 | S-1 | S-1 | 0000950170-25-030286 | 333-285476 | 25693590 | 33 | 2616651 | |||
| 2025-02-26 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000537 | 333-284969 | 25672543 | 33 | 1750 | ||
| 2025-02-24 | CORRESP | filename1.htm | 0000950170-25-025930 | 8925 | ||||||
| 2025-02-21 | UPLOAD | filename1.pdf | 0000000000-25-002044 | 333-284969 | 40094 | |||||
| 2025-02-14 | S-3 | S-3 | 0000950170-25-021191 | 333-284969 | 25628782 | 33 | 2668567 | |||
| 2025-02-14 | 10-K | 10-K | 0000950170-25-020467 | 001-37746 | 25623597 | 34 | 14742252 | 1 | 1 | |
| 2025-02-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-020465 | 001-37746 | 25623581 | 34 | 405533 | 1 | 1 |
| 2025-02-11 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-017473 | 001-37746 | 25607792 | 34 | 21537971 | 1 | 1 |
| 2025-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002033916-25-000016 | 005-89584 | 25607161 | 34 | 10804 | |||
| 2025-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002033916-25-000004 | 005-89584 | 25606041 | 34 | 9232 | |||
| 2025-01-02 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000028 | 333-283983 | 25503633 | 33 | 1750 | ||
| 2025-01-02 | CORRESP | filename1.htm | 0000950170-25-000095 | 9681 | ||||||
| 2024-12-30 | UPLOAD | filename1.pdf | 0000000000-24-014315 | 333-283983 | 40078 | |||||
| 2024-12-20 | S-3 | S-3 | 0000950170-24-139087 | 333-283983 | 241568403 | 33 | 1497654 | |||
| 2024-12-12 | 8-K | 8-K | 1.01,3.02,9.01 | 0000950170-24-135890 | 001-37746 | 241545957 | 34 | 525191 | 1 | 1 |
| 2024-12-12 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-135609 | 001-37746 | 241543369 | 34 | 200004 | 1 | 1 |
| 2024-12-04 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-133091 | 001-37746 | 241524954 | 34 | 195103 | 1 | 1 |
| 2024-12-03 | 8-K | 8-K | 5.03,9.01 | 0000950170-24-132855 | 001-37746 | 241523600 | 34 | 193433 | 1 | 1 |
| 2024-11-26 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-130763 | 001-37746 | 241498282 | 34 | 191197 | 1 | 1 |
| 2024-11-22 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-129971 | 001-37746 | 241486662 | 34 | 205303 | 1 | 1 |
| 2024-11-20 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-129018 | 001-37746 | 241478360 | 34 | 199211 | 1 | 1 |
| 2024-11-14 | SC 13G/A | armistice-apvo093024a1.htm | 0001172661-24-005117 | 005-89584 | 241461194 | 34 | 90413 | |||
| 2024-11-08 | SC 13G | APVO 13G | 0002033916-24-000031 | 005-89584 | 241440052 | 34 | 58979 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-122837 | 001-37746 | 241433354 | 34 | 7637449 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-122830 | 001-37746 | 241433324 | 34 | 391519 | 1 | 1 |
| 2024-11-04 | 8-K | 8-K | 1.01,3.03,9.01 | 0000950170-24-120188 | 001-37746 | 241420278 | 34 | 198226 | 1 | 1 |
| 2024-10-25 | 8-K | 8-K | 5.07 | 0000950170-24-117439 | 001-37746 | 241397426 | 34 | 171915 | 1 | 1 |
| 2024-10-03 | DEF 14A | DEF 14A | 0000950170-24-112395 | 001-37746 | 241352120 | 34 | 2561694 | |||
| 2024-09-23 | PRE 14A | PRE 14A | 0000950170-24-108772 | 001-37746 | 241316710 | 34 | 1575821 | |||
| 2024-09-18 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-24-107776 | 001-37746 | 241307524 | 34 | 2629934 | 1 | 1 |
| 2024-09-17 | 424B4 | 424B4 | 0000950170-24-107412 | 333-281892 | 241305476 | 33 | 1215683 | |||
| 2024-09-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-09-16 09:00:00 | 9999999995-24-002853 | 333-281892 | 241302418 | 33 | 1751 | ||
| 2024-09-16 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-106614 | 001-37746 | 241299385 | 34 | 203386 | 1 | 1 |
| 2024-09-11 | CORRESP | filename1.htm | 0000950170-24-105597 | 12809 | ||||||
| 2024-09-11 | CORRESP | filename1.htm | 0000950170-24-105596 | 9967 | ||||||
| 2024-09-06 | UPLOAD | filename1.pdf | 0000000000-24-010107 | 333-281892 | 40023 | |||||
| 2024-08-30 | S-1 | S-1 | 0000950170-24-102458 | 333-281892 | 241271218 | 33 | 2658594 | |||
| 2024-08-09 | 4 | 4 | 0000950170-24-094819 | 6800 | ||||||
| 2024-08-09 | 4 | 4 | 0000950170-24-094816 | 10350 | ||||||
| 2024-08-09 | 4 | 4 | 0000950170-24-094813 | 6850 | ||||||
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-093366 | 001-37746 | 241186234 | 34 | 7009714 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-093356 | 001-37746 | 241186199 | 34 | 386759 | 1 | 1 |
| 2024-08-07 | 8-K | 8-K | 5.07 | 0000950170-24-092865 | 001-37746 | 241184281 | 34 | 170988 | 1 | 1 |
| 2024-07-19 | 4 | 4 | 0000950170-24-084958 | 5209 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084955 | 5363 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084954 | 5218 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084953 | 5317 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084952 | 5302 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084950 | 5300 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084947 | 5212 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084946 | 5224 | ||||||
| 2024-07-19 | 4 | 4 | 0000950170-24-084944 | 5233 | ||||||
| 2024-07-15 | DEF 14A | DEF 14A | 0000950170-24-083313 | 001-37746 | 241115909 | 34 | 1555111 | |||
| 2024-07-12 | S-8 | S-8 | 0000950170-24-083225 | 333-280789 | 241114882 | 33 | 155044 | |||
| 2024-07-03 | PRE 14A | PRE 14A | 0000950170-24-081568 | 001-37746 | 241100463 | 34 | 1552959 | |||
| 2024-07-01 | 8-K | 8-K | 3.01 | 0000950170-24-079672 | 001-37746 | 241091074 | 34 | 158334 | 1 | 1 |
| 2024-07-01 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-24-079653 | 001-37746 | 241090987 | 34 | 2352730 | 1 | 1 |
| 2024-06-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-06-28 09:00:00 | 9999999995-24-002018 | 333-280226 | 241087731 | 33 | 1751 | ||
| 2024-06-28 | 424B4 | 424B4 | 0000950170-24-079124 | 333-280226 | 241086541 | 33 | 1186757 | |||
| 2024-06-26 | S-1/A | S-1/A | 0000950170-24-077621 | 333-280226 | 241070701 | 33 | 1793816 | |||
| 2024-06-25 | CORRESP | filename1.htm | 0000950170-24-077100 | 9655 | ||||||
| 2024-06-20 | UPLOAD | filename1.pdf | 0000000000-24-007051 | 333-280226 | 40288 | |||||
| 2024-06-14 | S-1 | S-1 | 0000950170-24-073737 | 333-280226 | 241045345 | 33 | 2656056 | |||
| 2024-06-10 | 8-K | 8-K | 5.07 | 0000950170-24-071338 | 001-37746 | 241033162 | 34 | 176427 | 1 | 1 |
| 2024-06-03 | 4 | 4 | 0000950170-24-068075 | 10601 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068073 | 10598 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068070 | 10622 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068068 | 10613 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068067 | 10665 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068036 | 7113 | ||||||
| 2024-05-08 | 10-Q | 10-Q | 0000950170-24-055096 | 001-37746 | 24924386 | 34 | 5895909 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-055087 | 001-37746 | 24924357 | 34 | 334751 | 1 | 1 |
| 2024-04-23 | ARS | ARS | 0000950170-24-046911 | 001-37746 | 24864982 | 34 | 2992495 | |||
| 2024-04-23 | DEFA14A | DEFA14A | 0000950170-24-046896 | 001-37746 | 24864902 | 34 | 655424 | |||
| 2024-04-23 | DEF 14A | DEF 14A | 0000950170-24-046881 | 001-37746 | 24864815 | 34 | 3398540 | |||
| 2024-04-15 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-24-044419 | 001-37746 | 24844841 | 34 | 1154123 | 1 | 1 |
| 2024-04-12 | 424B4 | 424B4 | 0000950170-24-044148 | 333-278103 | 24842474 | 33 | 1153649 | |||
| 2024-04-10 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-04-10 09:00:00 | 9999999995-24-000919 | 333-278103 | 24837032 | 33 | 1750 | ||
| 2024-04-09 | S-1/A | S-1/A | 0000950170-24-043059 | 333-278103 | 24833644 | 33 | 1696475 | |||
| 2024-04-08 | CORRESP | filename1.htm | 0000950170-24-042692 | 12818 | ||||||
| 2024-04-08 | CORRESP | filename1.htm | 0000950170-24-042691 | 11923 | ||||||
| 2024-03-29 | CORRESP | filename1.htm | 0000950170-24-038749 | 26467 | ||||||
| 2024-03-29 | S-1/A | S-1/A | 0000950170-24-038743 | 333-278103 | 24804678 | 33 | 1742980 | |||
| 2024-03-29 | UPLOAD | filename1.pdf | 0000000000-24-003386 | 333-278103 | 43357 | |||||
| 2024-03-20 | S-1 | S-1 | 0000950170-24-034178 | 333-278103 | 24767983 | 33 | 2650563 | |||
| 2024-03-07 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-027613 | 001-37746 | 24728285 | 34 | 204895 | 1 | 1 |
| 2024-03-05 | 8-K | 8-K | 5.03,9.01 | 0000950170-24-026223 | 001-37746 | 24722049 | 34 | 186920 | 1 | 1 |
| 2024-03-05 | 4 | 4 | 0000950170-24-025921 | 10393 | ||||||
| 2024-03-05 | 4 | 4 | 0000950170-24-025915 | 10331 | ||||||
| 2024-03-05 | 4 | 4 | 0000950170-24-025881 | 10366 | ||||||
| 2024-03-05 | 4 | 4 | 0000950170-24-025878 | 10332 | ||||||
| 2024-03-05 | 10-K | 10-K | 0000950170-24-025428 | 001-37746 | 24718389 | 34 | 11844299 | 1 | 1 | |
| 2024-03-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-025427 | 001-37746 | 24718371 | 34 | 340195 | 1 | 1 |
| 2024-02-14 | SC 13G | armistice-apvo123123.htm | 0001172661-24-001314 | 005-89584 | 24636767 | 34 | 90401 | |||
| 2024-02-06 | 8-K | 8-K | 5.07 | 0000950170-24-011766 | 001-37746 | 24600813 | 34 | 168152 | 1 | 1 |
| 2024-01-30 | 4 | 4 | 0000950170-24-009005 | 6839 | ||||||
| 2024-01-30 | 4 | 4 | 0000950170-24-009003 | 6778 | ||||||
| 2024-01-30 | 4 | 4 | 0000950170-24-009002 | 6836 | ||||||
| 2024-01-30 | DEFR14A | DEFR14A | 0000950170-24-008535 | 001-37746 | 24575901 | 34 | 38893 | |||
| 2024-01-16 | DEFR14A | DEFR14A | 0000950170-24-004620 | 001-37746 | 24535314 | 34 | 427804 | |||
| 2023-12-22 | DEF 14A | DEF 14A | 0000950170-23-072644 | 001-37746 | 231509943 | 34 | 2839372 | |||
| 2023-12-12 | PRE 14A | PRE 14A | 0000950170-23-069702 | 001-37746 | 231481467 | 34 | 1694087 | |||
| 2023-11-30 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-11-30 17:30:00 | 9999999995-23-003508 | 333-275710 | 231457414 | 33 | 1702 | ||
| 2023-11-29 | CORRESP | filename1.htm | 0000950170-23-066620 | 9298 | ||||||
| 2023-11-29 | UPLOAD | filename1.pdf | 0000000000-23-012981 | 40292 | ||||||
| 2023-11-22 | S-3 | S-3 | 0000950170-23-065871 | 333-275710 | 231433434 | 33 | 707644 | |||
| 2023-11-14 | 10-Q | 10-Q | 0000950170-23-063379 | 001-37746 | 231401757 | 34 | 8021047 | 1 | 1 | |
| 2023-11-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-063369 | 001-37746 | 231401699 | 34 | 470307 | 1 | 1 |
| 2023-11-09 | 8-K | 8-K | 1.01,3.02,9.01 | 0000950170-23-062234 | 001-37746 | 231393792 | 34 | 1256693 | 1 | 1 |
| 2023-11-03 | 8-K | 8-K | 1.01,3.03,9.01 | 0000950170-23-058840 | 001-37746 | 231376510 | 34 | 209486 | 1 | 1 |
| 2023-09-15 | 8-K | 8-K | 3.01 | 0000950170-23-048392 | 001-37746 | 231259133 | 34 | 166157 | 1 | 1 |
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045306 | 7025 | ||||||
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045303 | 7037 | ||||||
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045301 | 7022 | ||||||
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045298 | 7031 | ||||||
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045294 | 7046 | ||||||
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045267 | 7170 | ||||||
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045265 | 7120 | ||||||
| 2023-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-045263 | 10976 | ||||||
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-040983 | 001-37746 | 231157336 | 34 | 8056456 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-040981 | 001-37746 | 231157283 | 34 | 546063 | 1 | 1 |
| 2023-08-07 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-23-038673 | 001-37746 | 231145282 | 34 | 1434252 | 1 | 1 |
| 2023-08-03 | 424B4 | 424B4 | 0000950170-23-038144 | 333-273067 | 231141236 | 33 | 531395 | |||
| 2023-08-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-08-01 17:30:00 | 9999999995-23-002244 | 333-273067 | 231133546 | 33 | 1702 | ||
| 2023-08-01 | S-1/A | S-1/A | 0000950170-23-036437 | 333-273067 | 231131548 | 33 | 1534719 | |||
| 2023-08-01 | CORRESP | filename1.htm | 0000950170-23-036237 | 22634 | ||||||
| 2023-08-01 | CORRESP | filename1.htm | 0000950170-23-036236 | 12110 | ||||||
| 2023-07-28 | CORRESP | filename1.htm | 0000950170-23-035319 | 22623 | ||||||
| 2023-07-28 | CORRESP | filename1.htm | 0000950170-23-035318 | 12254 | ||||||
| 2023-07-26 | CORRESP | filename1.htm | 0000950170-23-034815 | 23005 | ||||||
| 2023-07-26 | CORRESP | filename1.htm | 0000950170-23-034762 | 12108 | ||||||
| 2023-07-21 | CORRESP | filename1.htm | 0000950170-23-033833 | 22131 | ||||||
| 2023-07-21 | CORRESP | filename1.htm | 0000950170-23-033832 | 12254 | ||||||
| 2023-07-18 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-033264 | 001-37746 | 231093054 | 34 | 232563 | 1 | 1 |
| 2023-07-14 | CORRESP | filename1.htm | 0000950170-23-033011 | 22655 | ||||||
| 2023-07-14 | CORRESP | filename1.htm | 0000950170-23-033010 | 12108 | ||||||
| 2023-07-14 | S-1/A | S-1/A | 0000950170-23-033000 | 333-273067 | 231089310 | 33 | 2376476 | |||
| 2023-07-06 | UPLOAD | filename1.pdf | 0000000000-23-007197 | 40247 | ||||||
| 2023-06-30 | S-1 | S-1 | 0000950170-23-031113 | 333-273067 | 231061940 | 33 | 1474960 | |||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033846 | 9313 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033841 | 9319 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033835 | 9307 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033830 | 9328 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033828 | 9304 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033823 | 7122 | ||||||
| 2023-06-02 | 8-K | 8-K | 5.07 | 0000950170-23-026092 | 001-37746 | 23989252 | 34 | 199098 | 1 | 1 |
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-020870 | 001-37746 | 23909012 | 34 | 7426924 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020863 | 001-37746 | 23908974 | 34 | 432467 | 1 | 1 |
| 2023-04-19 | DEFA14A | DEFA14A | 0000950170-23-013365 | 001-37746 | 23828534 | 34 | 1368688 | |||
| 2023-04-18 | ARS | ARS | 0000950170-23-013176 | 001-37746 | 23825575 | 34 | 1667778 | |||
| 2023-04-18 | DEF 14A | DEF 14A | 0000950170-23-013175 | 001-37746 | 23825569 | 34 | 3322585 | |||
| 2023-03-30 | 10-K | 10-K | 0000950170-23-010757 | 001-37746 | 23777198 | 34 | 11605420 | 1 | 1 | |
| 2023-03-30 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-010755 | 001-37746 | 23777181 | 34 | 466484 | 1 | 1 |
| 2023-03-30 | 8-K | 8-K | 1.01,1.02,7.01,9.01 | 0000950170-23-010752 | 001-37746 | 23777167 | 34 | 218145 | 1 | 1 |
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016789 | 11674 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016786 | 11687 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016783 | 11736 | ||||||
| 2023-03-07 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-016778 | 4214 | ||||||
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016774 | 11680 | ||||||
| 2023-03-07 | 3 | FORM 3 SUBMISSION | 0001209191-23-016753 | 17910 | ||||||
| 2023-03-07 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-006384 | 001-37746 | 23711091 | 34 | 182312 | 1 | 1 |
| 2023-02-14 | SC 13G/A | APTEVO THERAPEUTICS INC. | 0000902664-23-001735 | 005-89584 | 23623932 | 34 | 61251 | |||
| 2023-02-13 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-002538 | 001-37746 | 23614831 | 34 | 251674 | 1 | 1 |
| 2023-01-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-005423 | 7091 | ||||||
| 2023-01-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-005420 | 7079 | ||||||
| 2023-01-09 | 8-K | 8-K | 8.01,9.01 | 0001564590-23-000273 | 001-37746 | 23516720 | 34 | 187846 | 1 | 1 |
| 2022-12-12 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-039215 | 001-37746 | 221456223 | 34 | 213854 | 1 | 1 |
| 2022-11-10 | 10-Q | 10-Q | 0001564590-22-037287 | 001-37746 | 221375116 | 34 | 8013871 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-037285 | 001-37746 | 221375071 | 34 | 472147 | 1 | 1 |
| 2022-11-04 | 8-K | 8-K | 1.01,3.03,9.01 | 0001564590-22-036769 | 001-37746 | 221362539 | 34 | 203173 | 1 | 1 |
| 2022-09-19 | 8-K | 8-K | 8.01,9.01 | 0000950123-22-009848 | 001-37746 | 221249659 | 34 | 212779 | 1 | 1 |
| 2022-08-11 | 10-Q | 10-Q | 0001564590-22-029025 | 001-37746 | 221153846 | 34 | 7538980 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-029023 | 001-37746 | 221153804 | 34 | 477822 | 1 | 1 |
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045193 | 5368 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045189 | 5461 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045188 | 5374 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045184 | 5383 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045183 | 10034 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045182 | 5359 | ||||||
| 2022-08-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-045181 | 5362 | ||||||
| 2022-06-09 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-022813 | 001-37746 | 221004969 | 34 | 218408 | 1 | 1 |
| 2022-06-08 | 8-K | 8-K | 1.01,8.01 | 0001564590-22-022767 | 001-37746 | 221003588 | 34 | 165410 | 1 | 1 |
| 2022-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-034879 | 6303 | ||||||
| 2022-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-034876 | 6325 | ||||||
| 2022-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-034873 | 6313 | ||||||
| 2022-06-07 | S-8 | S-8 | 0001564590-22-022706 | 333-265468 | 221001889 | 33 | 185857 | |||
| 2022-06-07 | 8-K | 8-K | 5.07 | 0001564590-22-022694 | 001-37746 | 221001701 | 34 | 191803 | 1 | 1 |
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-033936 | 9792 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-033933 | 7089 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-033930 | 10470 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-033928 | 12454 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-033924 | 9785 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-033920 | 9776 | ||||||
| 2022-05-31 | 8-K | 8-K | 8.01 | 0001564590-22-021764 | 001-37746 | 22980653 | 34 | 159541 | 1 | 1 |
| 2022-05-12 | 10-Q | 10-Q | 0001564590-22-019685 | 001-37746 | 22915846 | 34 | 6233094 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-019680 | 001-37746 | 22915801 | 34 | 402608 | 1 | 1 |
| 2022-04-27 | DEF 14A | DEF 14A | 0001564590-22-015884 | 001-37746 | 22856476 | 34 | 2394167 | |||
| 2022-04-07 | 8-K | 8-K | 3.01 | 0001564590-22-013856 | 001-37746 | 22814148 | 34 | 162154 | 1 | 1 |
| 2022-03-30 | 8-K/A | 8-K/A | 8.01,9.01 | 0001564590-22-012331 | 001-37746 | 22783324 | 34 | 175693 | 1 | 1 |
| 2022-03-29 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-012068 | 001-37746 | 22777488 | 34 | 192690 | 1 | 1 |
| 2022-03-29 | 424B5 | 424B5 | 0001564590-22-012065 | 333-251318 | 22777448 | 33 | 32703 | |||
| 2022-03-24 | 424B5 | 424B5 | 0001564590-22-011578 | 333-251318 | 22764793 | 33 | 32706 | |||
| 2022-03-24 | 10-K | 10-K | 0001564590-22-011575 | 001-37746 | 22764766 | 34 | 10674866 | 1 | 1 | |
| 2022-03-24 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-22-011574 | 001-37746 | 22764749 | 34 | 425349 | 1 | 1 |
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016457 | 8055 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016453 | 8068 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016448 | 8070 | ||||||
| 2022-02-18 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-005709 | 001-37746 | 22653256 | 34 | 178670 | 1 | 1 |
| 2022-02-18 | 424B5 | 424B5 | 0001564590-22-005705 | 333-251318 | 22652955 | 33 | 606982 | |||
| 2022-02-17 | 8-K | 8-K | 1.01,9.01 | 0001564590-22-005567 | 001-37746 | 22648293 | 34 | 755527 | 1 | 1 |
| 2022-02-10 | SC 13G/A | apvo-13g_20211231.txt | 0001037389-22-000012 | 005-89584 | 22613509 | 34 | 13309 | |||
| 2022-02-09 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-004304 | 001-37746 | 22603881 | 34 | 205550 | 1 | 1 |
| 2022-02-01 | 4 | xslF345X03/white.xml | 0001019056-22-000114 | 6985 | ||||||
| 2022-02-01 | 4 | xslF345X03/lamothe.xml | 0001019056-22-000112 | 6983 | ||||||
| 2022-01-21 | 8-K | APVO-2022-01-21 8K | 5.02,7.01,9.01 | 0001564590-22-001848 | 001-37746 | 22544178 | 34 | 196310 | 1 | 1 |
| 2021-12-07 | 4 | xslF345X03/elhibri.xml | 0001019056-21-000634 | 10572 | ||||||
| 2021-11-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-066910 | 20533 | ||||||
| 2021-11-26 | SC 13D/A | AMENDMENT NO. 5 | 0001214659-21-012287 | 005-89584 | 211450966 | 34 | 69148 | |||
| 2021-11-23 | 8-K | APVO-2021-11-23 8K | 8.01,9.01 | 0001564590-21-057958 | 001-37746 | 211434770 | 34 | 198690 | 1 | 1 |
| 2021-11-22 | SC 13D/A | AMENDMENT NO. 4 | 0001214659-21-012163 | 005-89584 | 211433744 | 34 | 72838 | |||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066146 | 26245 | ||||||
| 2021-11-12 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-056501 | 001-37746 | 211399839 | 34 | 467362 | 1 | 1 |
One latest value per concept from companyfacts (335 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 3.46M | 2026-11-16 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 9.80M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 960,054 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-31 | 0001193125-26-328604 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 952,574 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-31 | 0001193125-26-328604 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 1.28M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-31 | 0001193125-26-328604 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.27M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-31 | 0001193125-26-328604 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 0 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-31 | 0001193125-26-328604 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 604.17 | 2026-11-20 | S-1 | 2026-11-20 | 0001193125-26-470268 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 604.17 | 2026-11-20 | S-1 | 2026-11-20 | 0001193125-26-470268 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 6.94M | 2026-11-20 | S-1 | 2026-11-20 | 0001193125-26-470268 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-20 | S-1 | 2026-11-20 | 0001193125-26-470268 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-20 | S-1 | 2026-11-20 | 0001193125-26-470268 | |||
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 2.22M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269598 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 7.02M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 4.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 593,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 14.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -105,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 301.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 51,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockSplit | Adjustments to Additional Paid in Capital, Stock Split | USD | -1,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 600,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-350559 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableNoncurrent | Accounts Receivable, Allowance for Credit Loss, Noncurrent | USD | 3.30M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 800,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 71.01M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | Assets | Assets | USD | 13.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 9.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 29.05M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperation | Disposal Group, Including Discontinued Operation, Assets | USD | 23.77M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 16.31M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 73.69M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 500,000 | 2021-03-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 | |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | -444,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityCurrent | Business Combination, Contingent Consideration, Liability, Current | USD | 444,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | CapitalExpenditureDiscontinuedOperations | Capital Expenditure, Discontinued Operations | USD | 0 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-13 | 0001564590-20-025066 |
| us-gaap | Cash | Cash | USD | 1.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 8.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -2.58M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 25.33M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-020870 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 8.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -13.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 6.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 491,403 | 2024-09-18 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072622 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 6.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 2.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 2.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 115,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -40.45M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 19.93M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 5.01M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -12.05M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | -2,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | -710,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | DebtInstrumentBasisSpreadOnVariableRate1 | Debt Instrument, Basis Spread on Variable Rate | pure | 0.076 | 2018-02-22 | 2018-02-23 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012733 |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.23 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019685 | |
| us-gaap | DeferredCostsCurrentAndNoncurrent | Deferred Costs | USD | 1.10M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026319 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -9.64M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | DeferredFinanceCostsGross | Debt Issuance Costs, Gross | USD | 1.10M | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019685 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | -1.36M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 7.49M | 2017-01-01 | 2017-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029562 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -10.54M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 800,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 811,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 2.90M | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -902,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | DeferredTaxAssetParentsBasisInDiscontinuedOperation | Deferred Tax Asset, Parent's Basis in Discontinued Operation | USD | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 67,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 55.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsInventory | Deferred Tax Assets, Inventory | USD | 1.72M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 800,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 43.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 17.75M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 3.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 486,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 397,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 797,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 3.46M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 12,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 54.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 2,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssets | Deferred Tax Liabilities, Goodwill and Intangible Assets | USD | 13.04M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 15.82M | 2016-06-30 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 575,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 224,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.06 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | Depreciation | Depreciation | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 106,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax | Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | USD | -1.58M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 |
| us-gaap | DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax | Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | USD | 1.24M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | DiscontinuedOperationTaxEffectOfDiscontinuedOperation | Discontinued Operation, Tax Effect of Discontinued Operation | USD | 999,000 | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-053058 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net | USD | 7.02M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities | Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities | USD | 878,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001564590-17-023382 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent | Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current | USD | 5.04M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 7.62M | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent | USD | 4.42M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationInventoryCurrent | Disposal Group, Including Discontinued Operation, Inventory, Current | USD | 6.14M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities | Disposal Group, Including Discontinued Operation, Other Liabilities, Current | USD | 419,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent | Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current | USD | 3.15M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | DisposalGroupNotDiscontinuedOperationGainLossOnDisposal | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | USD | 9.65M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | Dividends | Dividends | USD | 2.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | DueFromOtherRelatedParties | Due from Other Related Parties | USD | 20.00M | 2016-08-04 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029562 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -15.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.55 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019685 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -15.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.197 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationDispositionOfBusiness | Effective Income Tax Rate Reconciliation, Disposition of Business, Percent | pure | -0.079 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.001 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.033 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.025 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.008 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.048 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares | Employee Stock Ownership Plan (ESOP), Number of Allocated Shares | shares | 84,900 | 2020-07-27 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | EscrowDeposit | Escrow Deposit | USD | 750,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 | |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | USD | 19,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | 463,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 444,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 1,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037287 |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 2,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037287 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 4.54M | 2016-06-30 | 2016 | Q2 | 10-Q/A | 2016-09-22 | 0000950123-16-020493 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 830,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 830,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 830,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 830,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 20.81M | 2016-06-30 | 2016 | Q2 | 10-Q/A | 2016-09-22 | 0000950123-16-020493 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 4.42M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | -47,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 14.34M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-053058 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 14.34M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 37.18M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 8.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | Goodwill | Goodwill | USD | 29.21M | 2016-06-30 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 41.80M | 2016-01-01 | 2016-09-30 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 29.20M | 2016-07-01 | 2016-09-30 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -25.97M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -25.97M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -19.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -1.59 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019685 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -87.38 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -87.38 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share | USD/shares | 0.04 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019685 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 164.87 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 164.87 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | IncomeTaxCreditsAndAdjustments | Income Tax Credits and Adjustments | USD | 400,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 1.36M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 1.38M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 5.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -5.45M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 75,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 848,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 652,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 1.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 600,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -157,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 2.70M | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-053058 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -191,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -3.71M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -3.71M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -595,000 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q/A | 2016-09-22 | 0000950123-16-020493 |
| us-gaap | IncreaseDecreaseInIncomeTaxes | Increase (Decrease) in Income Taxes | USD | 1.38M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 5.70M | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-053058 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | -1.51M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020781 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 10,000 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q/A | 2016-09-22 | 0000950123-16-020493 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -35,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | IncreaseDecreaseInRestrictedCashForOperatingActivities | Increase (Decrease) in Restricted Cash for Operating Activities | USD | 400,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 1.78M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 1.93M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 3.69M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 6.14M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | InventoryRawMaterialsAndSuppliesNetOfReserves | Inventory, Raw Materials and Supplies, Net of Reserves | USD | 491,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 1.96M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 7.10M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.20M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 |
| us-gaap | LeaseCost | Lease, Cost | USD | 890,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 5.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.40M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041524 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.40M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 418,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041524 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | Liabilities | Liabilities | USD | 9.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 13.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 6.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Liabilities, Current | USD | 8.13M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | LineOfCreditFacilityAnnualPrincipalPayment | Line of Credit Facility, Annual Principal Payment | USD | 20.00M | 2020-02-27 | 2020-02-28 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-053058 |
| us-gaap | LineOfCreditFacilityMaximumBorrowingCapacity | Line of Credit Facility, Maximum Borrowing Capacity | USD | 25.00M | 2020-08-05 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 | |
| us-gaap | LoansPayableCurrent | Loans Payable, Current | USD | 19.71M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041524 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 2.00M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths | Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months | USD | 2.28M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three | USD | 1.44M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two | USD | 1.73M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 1.46M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 | |
| us-gaap | LongTermLoansPayable | Loans Payable, Noncurrent | USD | 2.36M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0001564590-22-029025 | |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 6.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 5.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -556,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012733 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -156,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 23.51M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012733 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -19.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -16.98M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012733 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -19.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -22.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -1.94M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | NumberOfReportingUnits | Number of Reporting Units | Unit | 1 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 14.90M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-14 | 0001564590-20-040295 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -19.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 890,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 4.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 947,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 3.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 3.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 810,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 2.51M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.73M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 8,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 103,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 664,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008184 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 554,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.12 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 205.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 702,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 967,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 68,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 105,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 1.49M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269598 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 28,000 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020781 |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 1.59M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029562 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 292,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | -287,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | PaymentsForRoyalties | Payments for Royalties | USD | 6.78M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 601,000 | 2018-01-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041524 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 758,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 16.54M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 156,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 15.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 1.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 460,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 4.02M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 | |
| us-gaap | ProceedsFromContributionsFromParent | Proceeds from Contributions from Parent | USD | 71.22M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 28.12M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 5.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 18.04M | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001564590-17-023382 |
| us-gaap | ProceedsFromIssuanceOfOtherLongTermDebt | Proceeds from Issuance of Other Long-term Debt | USD | 24.73M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0001564590-22-011575 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 18,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 5.56M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | ProceedsFromRepaymentsOfRestrictedCashFinancingActivities | Proceeds from (Repayments of) Restricted Cash, Financing Activities | USD | -10.00M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | ProceedsFromRoyaltiesReceived | Proceeds from Royalties Received | USD | 33.90M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 90.24M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 220,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 557,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -19.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 14.45M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 353,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 200,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001564590-17-005738 |
| us-gaap | ReceivablesLongTermContractsOrPrograms | Receivables, Long-term Contracts or Programs | USD | 3.66M | 2021-12-31 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037287 | |
| us-gaap | RepaymentsOfLinesOfCredit | Repayments of Lines of Credit | USD | 22.10M | 2020-02-27 | 2020-02-28 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-053058 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 11.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 1.26M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 400,000 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020781 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 400,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 12.45M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020781 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 1.26M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 7.50M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016875 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -297.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 3.11M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 12.50M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0000950170-23-010757 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 5.41M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037287 |
| us-gaap | RoyaltyIncomeNonoperating | Royalty Income, Nonoperating | USD | 2.50M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025428 |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 4.07M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012733 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 4.07M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012733 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 25.34M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-25 | 0001564590-20-012791 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 166,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269598 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 31,986 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019685 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2,731.66 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-14 | 0000950170-25-020467 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 0 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041524 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 1.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | SharePrice | Share Price | USD/shares | 49.32 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 58.5 | 2025-06-20 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 9.19M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001564590-18-029562 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 3.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 | |
| us-gaap | StockholdersEquityNoteSpinoffTransaction | Stockholders' Equity Note, Spinoff Transaction | USD | 20,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.02 | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 24.8 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001564590-21-056494 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 4.32M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | -756,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | -2,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 25,000 | 2021-04-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0001564590-21-043955 |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 1.40M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005384 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 5.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126278 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 600,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063379 |
| us-gaap | WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount | WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount | USD | 97,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 1.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 4.94M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019685 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 1.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462265 |